Newberg Michael H, McEvers Kimberly J, Gorgone Darci A, Lifton Michelle A, Baumeister Susanne H C, Veazey Ronald S, Schmitz Jörn E, Letvin Norman L
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
J Immunol. 2006 Jan 1;176(1):319-28. doi: 10.4049/jimmunol.176.1.319.
Because the control of HIV-1 replication is largely dependent on CD8+ T lymphocyte responses specific for immunodominant viral epitopes, vaccine strategies that increase the breadth of dominant epitope-specific responses should contribute to containing HIV-1 spread. Developing strategies to elicit such broad immune responses will require an understanding of the mechanisms responsible for focusing CD8+ T lymphocyte recognition on a limited number of epitopes. To explore this biology, we identified cohorts of rhesus monkeys that expressed the MHC class I molecules Mamu-A01, Mamu-A02, or both, and assessed the evolution of their dominant epitope-specific CD8+ T lymphocyte responses (Gag p11C- and Tat TL8-specific in the Mamu-A01+ and Nef p199RY-specific in the Mamu-A02+ monkeys) following acute SIV infection. The Mamu-A02+ monkeys that also expressed Mamu-A01 exhibited a significant delay in the evolution of the CD8+ T lymphocyte responses specific for the dominant Mamu-A02-restricted SIV epitope, Nef p199RY. This delay in kinetics was not due to differences in viral load kinetics or magnitude or in viral escape mutations, but was associated with the evolution of the Mamu-A01-restricted CD8+ T lymphocyte responses to the highly dominant SIV epitopes Gag p11C and Tat TL8. Thus, the evolution of dominant epitope-specific CD8+ T lymphocyte responses can be suppressed by other dominant epitope-specific responses, and this immunodomination is important in determining the kinetics of dominant epitope-specific responses.
由于HIV-1复制的控制在很大程度上依赖于针对免疫显性病毒表位的CD8+ T淋巴细胞反应,因此增加显性表位特异性反应广度的疫苗策略应有助于遏制HIV-1的传播。制定引发此类广泛免疫反应的策略需要了解将CD8+ T淋巴细胞识别集中于有限数量表位的机制。为了探究这一生物学现象,我们鉴定了表达MHC I类分子Mamu-A01、Mamu-A02或两者皆有的恒河猴群体,并评估了它们在急性SIV感染后显性表位特异性CD8+ T淋巴细胞反应(Mamu-A01+群体中针对Gag p11C和Tat TL8特异性反应,Mamu-A02+群体中针对Nef p199RY特异性反应)的演变情况。同时表达Mamu-A01的Mamu-A02+恒河猴在针对显性Mamu-A02限制性SIV表位Nef p199RY的CD8+ T淋巴细胞反应演变方面出现了显著延迟。这种动力学延迟并非由于病毒载量动力学、幅度或病毒逃逸突变的差异所致,而是与Mamu-A01限制性CD8+ T淋巴细胞对高度显性SIV表位Gag p11C和Tat TL8的反应演变相关。因此,显性表位特异性CD8+ T淋巴细胞反应的演变可被其他显性表位特异性反应所抑制,并且这种免疫显性在决定显性表位特异性反应的动力学方面很重要。